Drug
Dcc 3009
Dcc 3009: highest development phase Phase 1/2, developed by Deciphera Pharmaceuticals, LLC. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Deciphera Pharmaceuticals, LLC
Trials
| Drug | Phase | Indication |
|---|---|---|
| DCC-3009 NCT06630234 | Phase 1/2 | Gastrointestinal Stromal Tumor (GIST) |
Latest
No recent events.
Follow Dcc 3009 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.